Zydus Inspection 2025: VAI Revised

  Published 6 months ago

Inspection (June 9‑18, 2025) revised facility from OAI to VAI; Zydus Lifesciences develops global therapies.

  • The inspection period spanned ten days, assessing compliance, safety, and operational practices at the facility overall
  • 2024 classification indicated Official Action Required; 2025 revision downgraded to voluntary corrective measures for compliance
  • Zydus Lifesciences focuses on the discovery, development, manufacturing, and marketing of diverse healthcare therapies worldwide today

You might like these

New India Assurance Secures Rs 30.8 Crore IT Deal

Kolte-Patil Developers Reports Strong FY25 Growth

Jane Street Faces SEBI Crackdown, Nuvama Impacted

July 2025 India WPI Deflation Hits Low

Talbros Secures $580 Crore Orders via JVs, Expands in Europe

Ujjivan SFB Jumps on Buy Rating

PNC Infratech to Build Bharatpur Flyover Project

News that matters the most ⚡